Add to ORKGA number of studies have shown a consistent reduction in pulmonary transfer factor (TLCO) after heart transplantation despite improvement in lung volumes and cardiopulmonary haemodynamics. The mechanism and causes of this decline have not been determined and the clinical significance of TLCO reduction in heart transplant recipients is unknown. The aims of the studies comprising this thesis were to describe prospectively the longitudinal changes in TLCO after heart transplantation, determine the mechanisms and causes of its decline and to evaluate the effect of TLCO reduction on gas exchange and exercise performance
Objective: to assess the impact of baseline pulmonary hypertension (PH) on early and long-term outco...
Objective: Cardiovascular disease is a major contributor to morbidity and mortality after organ tran...
Background: Graft right ventricular (RV) function is compromised directly posttransplant, especially...
A number of studies have shown a consistent reduction in pulmonary transfer factor (TLCO) after hear...
AbstractObjectives. The purpose of this study was to determine whether heart transplantation has an ...
Introduction: Investigations have described a correlation between the severity of heart failure and ...
Introduction: Investigations have described a correlation between the severity of heart failure and ...
The incidence of MCS for early graft dysfunction (EGD) following heart transplantation varies from 2...
The cardiovascular, pulmonary and musculoskeletal systems were investigated in seven studies of pati...
There is a need to expand knowledge on cardio-pulmonary pathophysiology of bronchiolitis obliterans ...
Objective: Pulmonary hypertension (PH) and elevated pulmonary vascular resistance (PVR) lead to poor...
Purpose: End-stage lung diseases result in anatomical changes of the thoracic cavity. However, very ...
Heart and lung transplantation activity is frustrated by the lack of availability of donor organs. T...
peer reviewedBackground: In the context of hematopoietic stem cell transplantation (HSCT), mesenchym...
Since the publication of the last edition of the Handbook of Physiology, lung transplantation has be...
Objective: to assess the impact of baseline pulmonary hypertension (PH) on early and long-term outco...
Objective: Cardiovascular disease is a major contributor to morbidity and mortality after organ tran...
Background: Graft right ventricular (RV) function is compromised directly posttransplant, especially...
A number of studies have shown a consistent reduction in pulmonary transfer factor (TLCO) after hear...
AbstractObjectives. The purpose of this study was to determine whether heart transplantation has an ...
Introduction: Investigations have described a correlation between the severity of heart failure and ...
Introduction: Investigations have described a correlation between the severity of heart failure and ...
The incidence of MCS for early graft dysfunction (EGD) following heart transplantation varies from 2...
The cardiovascular, pulmonary and musculoskeletal systems were investigated in seven studies of pati...
There is a need to expand knowledge on cardio-pulmonary pathophysiology of bronchiolitis obliterans ...
Objective: Pulmonary hypertension (PH) and elevated pulmonary vascular resistance (PVR) lead to poor...
Purpose: End-stage lung diseases result in anatomical changes of the thoracic cavity. However, very ...
Heart and lung transplantation activity is frustrated by the lack of availability of donor organs. T...
peer reviewedBackground: In the context of hematopoietic stem cell transplantation (HSCT), mesenchym...
Since the publication of the last edition of the Handbook of Physiology, lung transplantation has be...
Objective: to assess the impact of baseline pulmonary hypertension (PH) on early and long-term outco...
Objective: Cardiovascular disease is a major contributor to morbidity and mortality after organ tran...
Background: Graft right ventricular (RV) function is compromised directly posttransplant, especially...